Hinge HealthHNGE.NValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Richly Valued” zone.
As of Oct 16, 2026, Hinge Health (HNGE.N) trades at a P/E of 75.00x, P/B of 23.20x, P/S of 11.10x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 96th percentile over the trailing 10Y window (vs. 96th percentile over 3Y); P/B sits at the 89th percentile over the trailing 10Y window (vs. 89th percentile over 3Y); P/S sits at the 99th percentile over the trailing 10Y window (vs. 99th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 85th percentile within its industry and the 91st percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 4.50%, ranking at the 46th percentile over the trailing 20Y window.
The P/E and P/B long-window percentiles differ by only 6.8 points, pointing to a consistent valuation read across both metrics. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here lean heavily on buybacks rather than cash dividends. Hinge Health operates in the Services sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NYSE: HNGE · HNGE
Want the full picture on whether Hinge Health (HNGE.N) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 75.00 | ||||||
| P/B (MRQ) | 23.20 | ||||||
| P/S (TTM) | 11.10 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 4.50% |